Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
Nia JulianOctober 22, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH

Nia JulianNovember 16, 2020
Next

Atea Pharmaceuticals Fierce 15 2020 Winner

Nia JulianSeptember 28, 2020

© 2020 Solasta Ventures. All Rights Reserved.